Loading…
DIA Europe 2019 has ended
Wednesday, February 6 • 15:15 - 16:15
#S0603: Value Assessment of Combinations in Oncology (or others): Questions and Steps toward Practical Solutions

Sign up or log in to save this to your schedule and see who's attending!

Component Type: Session

The panel will discuss likely solutions for allowing patients to get access to combination drugs in oncology in a fast and sustainable manner. Panellists will also describe positive developments and highlight what they see as practical ways to advance the debate on this critical matter for the treatment of oncology.

Chair

Meni Styliadou

Speaker

Panelist
Francis Arickx

Panelist
Fiona Carlin

Panelist
Michael Schroter, PhD, MBA

Panelist
Timothy Wilsdon, MS



Speakers
avatar for Francis Arickx

Francis Arickx

Head of the Directorate Pharmaceutical Policy, National Institute for Health and Disability Insurance (RIZIV-INAMI)
Francis Arickx is head of the directorate Reimbursement of Medicines and Pharmaceutical Policy within the Health Care Department at the National Institute for Health and Disability Insurance (NIHDI RIZIV/INAMI) in Belgium. He manages administrative and scientific assessments, and... Read More →
FC

Fiona Carlin

Partner, Baker McKenzie
MS

Michael Schroter

Founding Partner, Viopas
Michael is a managing partner at Viopas, a venture capital and asset management firm investing in privately held and listed companies with a sustainable healthcare focus. As such Viopas favours investments in solutions which deliver cost-effective and improved clinical outcomes. Prior... Read More →
MS

Meni Styliadou

VP Government Affairs & Public Policy, Europe & Canada, Takeda
TW

Timothy Wilsdon

Principal, Charles River Associates International


Wednesday February 6, 2019 15:15 - 16:15
K1 Austria Center Vienna Bruno-Kreisky-Platz 1 1220 Vienna Austria
  • Featured Topics Value and Access
  • Tags Session